Skip to main content
Caplight Logo









DxGen Corp.

DxGen Corp.

Private
Gunpo-siHealthcare & Life Scienceshttps://dxgenco.com/

Last Round

Series B

Jan 31, 2019

Total Funding Raised

$5.78M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DxGen Corp. is a healthcare company that develops and manufactures point-of-care diagnostic analyzers and test kits for diabetes and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOCclinical chemistry analyzermedical device manufacturerimmunoassaydiagnostic test kitsdiabetes monitoringlipid profile testingrapid testingbedside testingin vitro diagnosticsIVDreagentsdiagnostic hardwaredecentralized testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DxGen Corp. Comparables

Compare DxGen Corp. with similar companies based on industry and business-model similarity.

DxGen Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chengdu Seamaty Technology Co., Ltd.
83%
Roche Holding
78%
Epinex Diagnostics, Inc.
77%

DxGen Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 31, 2019

DxGen Corp. Investors

Notable investors and investment history

DxGen Corp. investors
InvestorRounds
BNH INVESTMENTSeries A
KB SecuritiesSeries B
Hana SecuritiesSeries B
HB InvestmentSeries B
LSK InvestmentSeries A
Woori BankSeries B
Shinhan Capital Co., Ltd.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors grew 332% MoM to 3.5K.

  • Jan 31, 2019

    $3.58M round with KB Securities and HB Investment.

DxGen Corp. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DxGen Corp. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DxGen Corp.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGunpo-si
Year Founded2016
Last FundingJan 31, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?